Lack of effect of α-tocopherol on in vitro angiogenesis

Microvascular Research

Volumn 72, Issue 1-2, 2006, Pages 12-19

  Navarra, Teresa ^a   Del Turco, Serena ^a   Papa, Angela ^a   Battaglia, Debora ^a   Lazzerini, Guido ^a   Basta, Giuseppina ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Tocopherol; Angiogenesis; Matrix metalloproteinases; Reactive oxygen species; VE cadherin

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2 INTEGRIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG SCREENING; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANTIGENS, CD; BROMODEOXYURIDINE; CADHERINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASES; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33746350463     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2006.04.003     Document Type: Article

References (45)

1. Albini A., Tosetti F., Benelli R., and Noonan D.M. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res. 65 (2005) 10637-10641
2. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., Cohen C., Moses M., Kilroy S., Arnold R.S., and Lambeth J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 715-720
3. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D.M., Schmidt A.M., and De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105 (2002) 816-822
4. Basta G., Lazzerini G., Del Turco S., Ratto G.M., Schmidt A.M., and De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1401-1407
5. Benelli R., Morini M., Carrozzino F., Ferrari N., Minghelli S., Santi L., Cassatella M., Noonan D.M., and Albini A. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J. 16 (2002) 267-269
6. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271 (1996) 21793-21797
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
8. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., and Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
9. Cavallaro U., and Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression. J. Neuro-oncol. 50 (2000) 63-70
10. Chan A.C., and Tran K. The uptake of (R,R,R)alpha-tocopherol by human endothelial cells in culture. Lipids 25 (1990) 17-21
11. Crosby C.V., Fleming P.A., Argraves W.S., Corada M., Zanetta L., Dejana E., and Drake C.J. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105 (2005) 2771-2776
12. Devaraj S., Li D., and Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 98 (1996) 756-763
13. Faruqi R., de la Motte C., and DiCorleto P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94 (1994) 592-600
14. Giraudo E., Primo L., Audero E., Gerber H.P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., and Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 273 (1998) 22128-22135
15. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
16. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
17. Ikeda S., Yamaoka-Tojo M., Hilenski L., Patrushev N.A., Anwar G.M., Quinn M.T., and Ushio-Fukai M. IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2295-2300
18. Ikeda S., Ushio-Fukai M., Zuo L., Tojo T., Dikalov S., Patrushev N.A., and Alexander R.W. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96 (2005) 467-475
19. Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., Tawa R., Sakurai H., and Yokoyama M. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155 (2001) 45-52
20. Klekotka P.A., Santoro S.A., and Zutter M.M. alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J. Biol. Chem. 276 (2001) 9503-9511
21. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., Kim R.Y., Rohan R.M., Colby K.A., Yeo K.T., and Adamis A.P. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98 (1996) 1667-1675
22. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., and Dagenais G.R. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 (2005) 1338-1347
23. Maulik N., and Das D.K. Redox signaling in vascular angiogenesis. Free Radical Biol. Med. 33 (2002) 1047-1060
24. Monte M., Davel L.E., and Sacerdote de Lustig E. Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur. J. Cancer 33 (1997) 676-682
25. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1104-1107
26. Pizzorusso T., Ratto G.M., Putignano E., and Maffei L. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J. Neurosci. 20 (2000) 2809-2816
27. Riemersma R.A., Wood D.A., Macintyre C.C., Elton R.A., Gey K.F., and Oliver M.F. Anti-oxidants and pro-oxidants in coronary heart disease. Lancet 337 (1991) 677
28. Rodriguez J.A., Nespereira B., Perez-Ilzarbe M., Eguinoa E., and Paramo J.A. Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. Cardiovasc. Res. 65 (2005) 665-673
29. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Lakka H.M., Vanharanta M., Salonen J.T., and Poulsen H.E. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107 (2003) 947-953
30. Shih S.C., Robinson G.S., Perruzzi C.A., Calvo A., Desai K., Green J.E., Ali I.U., Smith L.E., and Senger D.R. Molecular profiling of angiogenesis markers. Am. J. Pathol. 161 (2002) 35-41
31. Shono T., Ono M., Izumi H., Jimi S.I., Matsushima K., Okamoto T., Kohno K., and Kuwano M. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16 (1996) 4231-4239
32. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., and Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (1996) 781-786
33. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 10 (2005) 1881-1896
34. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol.: Lung Cell Mol. Physiol. 279 (2000) L1005-L1028
35. Turley J.M., Funakoshi S., Ruscetti F.W., Kasper J., Murphy W.J., Longo D.L., and Birchenall-Roberts M.C. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ. 6 (1995) 655-663
36. Upston J.M., Kritharides L., and Stocker R. The role of vitamin E in atherosclerosis. Prog. Lipid Res. 42 (2003) 405-422
37. Ushio-Fukai M., and Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 264 (2004) 85-97
38. van der Wal A.C., and Becker A.E. Atherosclerotic plaque rupture-Pathologic basis of plaque stability and instability. Cardiovasc. Res. 41 (1999) 334-344
39. Vega-Lopez S., Kaul N., Devaraj S., Cai R.Y., German B., and Jialal I. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 53 (2004) 236-240
40. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
41. Wary K.K., Thakker G.D., Humtsoe J.O., and Yang J. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol. Cancer 2 (2003) 25
42. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
43. Wu D., Koga T., Martin K.R., and Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 147 (1999) 297-307
44. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., and Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 17 (1997) 4015-4023
45. Yusuf S., Dagenais G., Pogue J., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342 (2000) 154-160